4//SEC Filing
Pang Phillip 4
Accession 0001209191-23-013683
CIK 0001706431other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:39 PM ET
Size
7.4 KB
Accession
0001209191-23-013683
Insider Transaction Report
Form 4
Pang Phillip
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-02-27$23.00/sh−8,920$205,186→ 189,400 total - Sale
Common Stock
2023-02-27$23.56/sh−1,400$32,984→ 188,000 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.47 to $23.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.47 to $23.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001787370
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:39 PM ET
- Size
- 7.4 KB